Innovative Pharmaceutical Consultants Inc is categorized under Industry Specialist Consultants in Dallas, TX and active since 1988.
Innovative Pharmaceutical Consultants Inc was established in 1988, and today employs 1 to 4, earning $1.000.000 to $2.499.999 per year. This is a Industry Specialist Consultants business, which does work in the B2B market, and is classified as a Industry Specialist Consultants, under code number 541611 by the NAICS.
If you are seeking more information, feel free to contact Jack Munn at the company’s single location by writing to 9786 Skillman St, Dallas, Texas TX 75243 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Innovative Pharmaceutical Consultants Inc |
| Contact Person: | Jack Munn |
| Address: | 9786 Skillman St, Dallas, Texas 75243 |
| Annual Revenue (USD): | $1.000.000 to $2.499.999 |
| Founded: | 1988 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Industry Specialist Consultants |
| SIC Code: | 8742 |
| NAICS Code: | 541611 |
| Share This Business: |
Innovative Pharmaceutical Consultants Inc was started in 1988 to provide professional Industry Specialist Consultants under the SIC code 8742 and NAICS code 541611. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $1.000.000 to $2.499.999 per annum.
Feel free to contact Jack Munn for inquiries that concern Innovative Pharmaceutical Consultants Inc by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Innovative Pharmaceutical Consultants Inc can be found at the coordinates as well as the street address 9786 Skillman St in Dallas, Texas 75243.
For its online presence, you may visit Innovative Pharmaceutical Consultants Inc’s website at and engage with its social media outlets through on Twitter and on Facebook.